Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection

被引：8
|
作者：
Clark, P. J. [1 ,2 ]
Thompson, A. J. V. [1 ,2 ]
McHutchison, J. G. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
基金：
英国医学研究理事会;
关键词：
INTERFERON-LAMBDA; PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; TELAPREVIR; GENOTYPE-1; INHIBITOR; THERAPY; TYPE-1;
D O I：
10.1038/clpt.2010.185
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development.(1) For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers, and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.
引用
收藏
页码：708 / 711
页数：4
相关论文
共 50 条
  • [21] IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population
    Shi, Xiaodong
    Pan, Yu
    Wang, Moli
    Wang, Dongsheng
    Li, Wanyu
    Jiang, Tao
    Zhang, Peng
    Chi, Xiumei
    Jiang, Yanfang
    Gao, Yanhang
    Zhong, Jin
    Sun, Bing
    Xu, Damo
    Jiang, Jing
    Niu, Junqi
    PLOS ONE, 2012, 7 (05):
  • [22] IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection
    Sato, Masaya
    Kato, Naoya
    Tateishi, Ryosuke
    Muroyama, Ryosuke
    Kowatari, Norie
    Li, Wenwen
    Goto, Kaku
    Otsuka, Motoyuki
    Shiina, Shuichiro
    Yoshida, Haruhiko
    Omata, Masao
    Koike, Kazuhiko
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (04) : 748 - 754
  • [23] Doubtful Role of IL28B Polymorphism in Occult Hepatitis B Infection
    Bes, Marta
    Vargas, Victor
    Piron, Maria
    Casamitjana, Natalia
    Esteban, Juan Ignacio
    Campos-Varela, Isabel
    Puig, Lluis
    Sauleda, Silvia
    INTERVIROLOGY, 2015, 58 (03) : 160 - 165
  • [24] Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b
    Tsubota, Akihito
    Shimada, Noritomo
    Atsukawa, Masanori
    Abe, Hiroshi
    Kato, Keizo
    Ika, Makiko
    Matsudaira, Hiroshi
    Nagatsuma, Keisuke
    Matsuura, Tomokazu
    Aizawa, Yoshio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 144 - 150
  • [25] Association between IL28B Polymorphisms and Spontaneous Clearance of Hepatitis B Virus Infection
    Kim, Seung Up
    Song, Ki Jun
    Chang, Hye Young
    Shin, Eui-Cheol
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Ahn, Sang Hoon
    PLOS ONE, 2013, 8 (07):
  • [26] Reply to miR-122, IL28B genotype and the response to interferon in chronic hepatitis C virus infection
    Heim, Markus
    NATURE REVIEWS IMMUNOLOGY, 2013, 13 (12) : 902 - 902
  • [27] The Effect of IL28B Gene Polymorphism on Treatment Response in Iranian Patients with Hepatitis C Virus Infection
    Zare, Fateme
    Hadinedoushan, Hossein
    Meybodi, Mohsen Akhondi
    Dehghanmanshadi, Mahdi
    Bafghi, Seyyed Ali Mirghanizade
    Vakili, Mahmood
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2016, 9 (12) : 1 - 6
  • [28] The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
    Younossi, Zobair M.
    Birerdinc, Aybike
    Estep, Mike
    Stepanova, Maria
    Afendy, Arian
    Baranova, Ancha
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [29] Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C
    Mah, Yone-Han
    Liu, Chen-Hua
    Chen, Chi-Ling
    Tseng, Tai-Chung
    Liu, Chun-Jen
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (11) : 953 - 960
  • [30] IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
    Suppiah, Vijayaprakash
    Moldovan, Max
    Ahlenstiel, Golo
    Berg, Thomas
    Weltman, Martin
    Abate, Maria Lorena
    Bassendine, Margaret
    Spengler, Ulrich
    Dore, Gregory J.
    Powell, Elizabeth
    Riordan, Stephen
    Sheridan, David
    Smedile, Antonina
    Fragomeli, Vincenzo
    Mueller, Tobias
    Bahlo, Melanie
    Stewart, Graeme J.
    Booth, David R.
    George, Jacob
    NATURE GENETICS, 2009, 41 (10) : 1100 - U74
12345